Canada – Israel R&D Call for Proposal 2022
Open Date:
01/02/2022Deadline for Submission:
28/06/2022Time zone:
IsraelSummary:
Israel Innovation Authority (“Authority”) and NRC IRAP International invite Israeli and Canadian companies to submit joint proposals for industrial research and development projects under the current Call for Proposals (CFP) Through the Eureka Program.
Relevant Technologies
All technologies
Participating Agencies
Program Description
Israel Innovation Authority (“Authority”) and NRC IRAP International invite Israeli and Canadian companies to submit joint proposals for industrial research and development projects under the current Call for Proposals (CFP) Through the Eureka Program.
Eureka is the world’s biggest public network for international cooperation in R&D and innovation, present in over 45 countries. It is a decentralised intergovernmental organisation aiming to boost the productivity and competitiveness of industries by funding and supporting international collaborative market-driven R&D projects.
All parties will provide all necessary assistance to project partners during project proposal, evaluation and monitoring phase. In addition, all parties will facilitate EUREKA application process and acquisition of the EUREKA label for accepted proposals.
The Authority and NRC IRAP will provide access to public funds for jointly labelled projects. Support shall be granted to each partner by its own Authorities, in accordance with existing laws, rules, regulations and national procedures.
The purpose of the Industrial R&D Program is to support greater collaboration among Canadian and Israeli companies and researchers.
* This program is operated under the Authority’s incentive program for R&D with International Partners and the incentive program for Pilots with International Partners.
Please read the full details in the Program Guidelines.
Budget
For Israeli companies, the Israel Innovation Authority provides grants of up to 50% of the company’s project budget.
For Canadian companies, NRC IRAP provides grants of up to CAD $500,000 of the company’s project budget as detailed in the following link:
Criteria
The preconditions and criteria for evaluation are detailed in the incentive program for R&D with International Partners and the incentive program for Pilots with International Partners.
Although this call invites proposals related to any technological or market area, special attention is being given to the following sectors:
- Health and bio-convergence, including healthy ageing, mental health, biomedicine and biomedical engineering.
- Digital technologies, AI, Quantum computing
- Agricultural technologies and agri-food technologies.
- Clean technologies and low carbon economy technologies, including materials for clean fuels, clean transportation/mobility, climate resilient building/infrastructure, renewable energy, water and waste water management.
Application Process
The deadline for submission is 28/06/22 at 12:00.
The application process is detailed in the incentive program for R&D with International Partners and the incentive program for Pilots with International Partners.
For Canadian companied, an Expression of Interest (EOI) process is required. Dead line for the EOI registration stage is 6 May 2022 and the deadline for the EOI submission is 20 May 2022. At the Israel Innovation Authority, the EOI stage is not mandator, but highly recommended and you can find the EOI form here. Please send it to the program manager, Ms. Yifat Hadaya at: Yifat.hadaya@innovationisrael.org.il
In addition to the on line submission to the Israel Innovation Authority and to the submission of the Canadian partner with NRC IRAP, a joint submission with EUREKA is a must and the joint submission form should be attached to the on-line submission to the Israel Innovation Authority.
In addition to the Israeli companies’ application to the Israel Innovation Authority, their foreign partners must apply to the funding authority in their country. Applications that would not be submitted to both countries will not be approved.